Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSS0393 Ointment in Adults With Mild to Moderate Atopic Dermatitis
NCT07158151Phase 2Completed
- Sponsor
- Reistone Biopharma
- Start
- Sep 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RSS0393 in atopic dermatitis (AD), sponsored by Reistone Biopharma. Started Sep 2025; status: completed.
02
Drugs
RSS0393
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07158151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07158151.